Lessons from McCune-Albright syndrome-associated intraductal papillary mucinous neoplasms GNAS-activating mutations in pancreatic carcinogenesis

JAMA Surgery

Volumn 149, Issue 8, 2014, Pages 858-862

  Parvanescu, Alina ^a,b   Cros, Jérôme ^b,c,d   Ronot, Maxime ^c,d   Hentic, Olivia ^a   Grybek, Virginie ^b   Couvelard, Anne ^b,d,e   Levy, Philippe ^a,d   Chanson, Philippe ^f,g   Ruszniewski, Philippe ^a,b,d   Sauvanet, Alain ^a,d   Gaujoux, Sebastien ^a,b,d  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b INSERM   (France)

^c BEAUJON HOSPITAL   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e BICHAT HOSPITAL   (France)

^f UNIVERSITÉ PARIS SACLAY   (France)

^g BICÊTRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GEMCITABINE;

ADULT; ALBRIGHT SYNDROME; ARTICLE; CANCER ADJUVANT THERAPY; COLLOID CARCINOMA; FEMALE; GENE MUTATION; HUMAN; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PREVALENCE; PRIORITY JOURNAL; SPIRAL COMPUTER ASSISTED TOMOGRAPHY;

ADENOCARCINOMA, MUCINOUS; CARCINOMA, PANCREATIC DUCTAL; CARCINOMA, PAPILLARY; FIBROUS DYSPLASIA, POLYOSTOTIC; GTP-BINDING PROTEIN ALPHA SUBUNITS, GS; HUMANS; MALE; MIDDLE AGED; MUTATION; PANCREATIC NEOPLASMS; RETROSPECTIVE STUDIES;

EID: 84906675721     PISSN: 21686254     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamasurg.2014.535     Document Type: Article

References (15)

1. Wu J, Matthaei H, Maitra A, et al. Recurrent GNAS mutations define an unexpected pathway for pancreatic cyst development. Sci Transl Med. 2011;3 (92):92ra66. doi: 10.1126/scitranslmed.3002543.
2. Wu J, Jiao Y, Dal Molin M, et al. Whole-exome sequencing of neoplastic cysts of the pancreas reveals recurrent mutations in components of ubiquitin-dependent pathways. Proc Natl Acad Sci U S A. 2011;108(52):21188- 21193.
3. Kanda M, Knight S, Topazian M, et al. Mutant GNAS detected in duodenal collections of secretin-stimulated pancreatic juice indicates the presence or emergence of pancreatic cysts. Gut. 2013;62(7):1024-1033.
4. Furukawa T, Kuboki Y, Tanji E, et al. Whole-exome sequencing uncovers frequent GNAS mutations in intraductal papillary mucinous neoplasms of the pancreas. Sci Rep. 2011;1:161. doi: 10.1038/srep00161.
5. Nault JC, FabreM, Couchy G, et al. GNAS-activating mutations define a rare subgroup of inflammatory liver tumors characterized by STAT3 activation. J Hepatol. 2012;56(1):184-191.
6. Gaujoux S, Salenave S, Ronot M, et al. Hepatobiliary and pancreatic neoplasms in patients with McCune-Albright syndrome. J Clin Endocrinol Metab. 2014;99(1):97-101. doi: 10.1210/jc.2013-1823.
7. Weinstein LS, Shenker A, Gejman PV, MerinoMJ, Friedman E, Spiegel AM. Activating mutations of the stimulatory G protein in theMcCune-Albright syndrome. N Engl J Med. 1991;325(24):1688-1695.
8. Hruban RH, Takaori K, Klimstra DS, et al. An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms. Am J Surg Pathol. 2004;28(8):977-987.
9. Dal Molin M, Matthaei H,Wu J, et al. Clinicopathological correlates of activating GNAS mutations in intraductal papillary mucinous neoplasm (IPMN) of the pancreas. Ann Surg Oncol. 2013;20(12):3802-3808.
10. Matthaei H,Wu J, Dal Molin M, et al. GNAS codon 201 mutations are uncommon in intraductal papillary neoplasms of the bile duct. HPB (Oxford). 2012;14(10):677-683.
11. Ong CK, Subimerb C, Pairojkul C, et al. Exome sequencing of liver fluke-associated cholangiocarcinoma. Nat Genet. 2012;44(6):690-693.
12. Ideno N, Ohtsuka T, Kono H, et al. Intraductal papillary mucinous neoplasms of the pancreas with distinct pancreatic ductal adenocarcinomas are frequently of gastric subtype. Ann Surg. 2013;258 (1):141-151.
13. Mino-Kenudson M, Fernández-del Castillo C, Baba Y, et al. Prognosis of invasive intraductal papillary mucinous neoplasm depends on histological and precursor epithelial subtypes. Gut. 2011;60(12):1712-1720.
14. Yopp AC, Katabi N, Janakos M, et al. Invasive carcinoma arising in intraductal papillary mucinous neoplasms of the pancreas: a matched control study with conventional pancreatic ductal adenocarcinoma. Ann Surg. 2011;253(5):968-974.
15. Nishikawa G, Sekine S, Ogawa R, et al. Frequent GNAS mutations in low-grade appendiceal mucinous neoplasms. Br J Cancer. 2013;108(4):951-958.